12-Nov-2026 18:18:18

CAPLIPOINTExpansion

CAPLIN POINT LABORATORIES Q2 FY27 CONCALL: MAINTAINS 20–25% FY27 US GROWTH & 25–26% PAT MARGIN GUIDANCE; TARGETS DOUBLING CSU REVENUE & PROFITABILITY, Q3–Q4 US MARGIN RECOVERY, ₹500–600 CR COL2 CAPEX & AUGUST 2027 COMMISSIONING

CAPLIN POINT LAB LTD.

← Back to feed